Items where authors include "Flaherty, J."

Article

Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Sandercock, P., Darbyshire, J., DeMets, D. et al. (2050 more authors) (2024) Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Nature Communications, 15. 924. ISSN 2041-1723

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Flaherty, J. and Garratt, E. orcid.org/0000-0001-5974-4141 (2023) Life history mapping: exploring journeys into and through housing and homelessness. Qualitative Research, 23 (5). pp. 1222-1243. ISSN 1468-7941

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Garratt, E. orcid.org/0000-0001-5974-4141 and Flaherty, J. (2021) ‘There’s nothing I can do to stop it’ : homelessness among autistic people in a British city. Disability & Society, 38 (9). pp. 1558-1584. ISSN 0968-7599

Preece, J. orcid.org/0000-0002-9713-5344, Garratt, E. orcid.org/0000-0001-5974-4141 and Flaherty, J. (2020) Living through continuous displacement : resisting homeless identities and remaking precarious lives. Geoforum, 116. pp. 140-148. ISSN 0016-7185

Book Section

Garratt, E. orcid.org/0000-0001-5974-4141, Flaherty, J. and Barronr, A. (2021) Life mapping. In: Barron, A., Browne, A.L., Ehgartner, U., Hall, S.M., Pottinger, L. and Ritson, J., (eds.) Methods for Change: Impactful social science methodologies for 21st century problems. Aspect & The University of Manchester. , Manchester , pp. 142-150.

Monograph

Garratt, E. orcid.org/0000-0001-5974-4141 and Flaherty, J. (2020) Homelessness in Oxford : risks and opportunities across housing and homeless transitions. Report. Centre for Social Investigation, Nuffield College, Oxford , Oxford.